The European Respiratory Society (ERS) International Congress 2023

Milan, Italy 09 September 2023 - 12 September 2023

Acetazolamide helps patients with COPD reach new peaks

02 Oct 2023 by

Acetazolamide helps to reduce the chances of altitude-related adverse health effects (ARAHE) in patients with chronic obstructive pulmonary disease (COPD) in a study reported at ERS.

Acetazolamide helps patients with COPD reach new peaks

02 Oct 2023

Tacrolimus or cyclosporine for CLAD: The better of 2 immunosuppressants

28 Sep 2023 by

Tacrolimus given once daily significantly reduced the 3-year incidence of chronic lung allograft dysfunction (CLAD) in lung transplant patients compared with standard immunosuppressant in the open label, multicentre, ScanCLAD trial presented at ERS 2023.

Tacrolimus or cyclosporine for CLAD: The better of 2 immunosuppressants

28 Sep 2023

Dupilumab improves lung function in children with moderate-to-severe type 2 asthma

26 Sep 2023 by

Treatment with dupilumab significantly improved lung function in children with moderate-to-severe type 2 asthma compared with placebo, according to two post hoc analyses presented at ERS 2023.

Dupilumab improves lung function in children with moderate-to-severe type 2 asthma

26 Sep 2023

Is CPAP cardioprotective?

25 Sep 2023 by

Two studies presented at ERS 2023 demonstrated the potential of a continuous positive airway pressure (CPAP) machine to address cardiovascular (CV) risks in individuals with obstructive sleep apnoea (OSA).

Is CPAP cardioprotective?

25 Sep 2023

Vaping tied to chronic stress, poor QoL in young adults

23 Sep 2023 by

Use of e-cigarette (EC) shows a significant relation with a higher incidence of chronic stress and is indicative of poorer quality of life (QoL) in young adults, suggests a study presented at ERS 2023.

Vaping tied to chronic stress, poor QoL in young adults

23 Sep 2023

Fatigue in COPD influenced by multiple contributing factors

22 Sep 2023 by

Fatigue in people with chronic obstructive pulmonary disease (COPD) may be caused by factors such as shortness of breath, sleep quality, pain, and fatigue-related catastrophizing, according to the FAntasTIGUE study.

Fatigue in COPD influenced by multiple contributing factors

22 Sep 2023

Benralizumab helps maintain severe asthma control with reduced ICS doses

22 Sep 2023 by

Treatment with benralizumab allows tapering of inhaled corticosteroid (ICS) doses for patients with severe eosinophilic asthma, without compromising disease control and increasing exacerbations, as shown in the results of the phase IV SHAMAL study.

Benralizumab helps maintain severe asthma control with reduced ICS doses

22 Sep 2023

Smoking speeds up ageing process

22 Sep 2023 by

A recent Mendelian randomization (MR) study provides genetic evidence showing that smoking can accelerate ageing as a result of shortened leucocyte telomere length (LTL). However, quitting may help reduce such risk.

Smoking speeds up ageing process

22 Sep 2023

Benralizumab reduces asthma exacerbations in Asians

22 Sep 2023 by

Treatment with benralizumab significantly reduces the annual asthma exacerbation rate (AAER) among Asian patients with severe uncontrolled asthma compared with placebo, according to a subgroup analysis of the MIRACLE trial presented at ERS 2023.

Benralizumab reduces asthma exacerbations in Asians

22 Sep 2023

Chlorpheniramine nasal spray alleviates long COVID symptoms

21 Sep 2023 by

Inhaled chlorpheniramine maleate appears to reduce the risk of prolonged post-COVID symptoms, according to a study presented at ERS Congress 2023.

Chlorpheniramine nasal spray alleviates long COVID symptoms

21 Sep 2023